ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.70
      0.13%
      US Tech 100
      17,617.63
      0.04%
      Dow Jones
      38,884.26
      0.08%
      Brent Oil
      82.715
      -0.18%
      Bitcoin
      62,542.55
      0.33%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. G1 Therapeutics Inc (GTHX)

      7. G1 Therapeutics Inc (GTHX) News

      GTHX

      G1 Therapeutics (GTHX)

      G1 Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GTHX
      DateTimeSourceHeadlineSymbolCompany
      12:51PMiHub NewswireFeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
      05/01/20245:50PMGlobeNewswire Inc.G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GTHXG1 Therapeutics Inc
      05/01/20246:30AMGlobeNewswire Inc.G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:GTHXG1 Therapeutics Inc
      05/01/20246:25AMGlobeNewswire Inc.G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for LerociclibNASDAQ:GTHXG1 Therapeutics Inc
      04/17/20249:00AMGlobeNewswire Inc.G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024NASDAQ:GTHXG1 Therapeutics Inc
      04/04/202410:30AMGlobeNewswire Inc.G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:GTHXG1 Therapeutics Inc
      04/01/20244:20PMGlobeNewswire Inc.G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GTHXG1 Therapeutics Inc
      03/01/20244:20PMGlobeNewswire Inc.G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GTHXG1 Therapeutics Inc
      02/28/20246:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTHXG1 Therapeutics Inc
      02/28/20246:30AMGlobeNewswire Inc.G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:GTHXG1 Therapeutics Inc
      02/27/20248:30AMGlobeNewswire Inc.G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:GTHXG1 Therapeutics Inc
      02/15/20248:30AMGlobeNewswire Inc.G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024NASDAQ:GTHXG1 Therapeutics Inc
      02/13/20246:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      02/12/20244:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      02/12/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTHXG1 Therapeutics Inc
      02/12/20244:05PMGlobeNewswire Inc.G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring CommitteeNASDAQ:GTHXG1 Therapeutics Inc
      01/09/20244:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      01/08/20246:45AMGlobeNewswire Inc.G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GTHXG1 Therapeutics Inc
      01/08/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTHXG1 Therapeutics Inc
      01/08/20246:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      01/08/20246:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      01/08/20246:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      01/08/20246:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      01/08/20246:02AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      01/08/20246:02AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      01/03/20249:00AMGlobeNewswire Inc.G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GTHXG1 Therapeutics Inc
      01/02/20247:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      01/02/20244:51PMGlobeNewswire Inc.G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GTHXG1 Therapeutics Inc
      12/13/20234:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTHXG1 Therapeutics Inc
      12/12/20234:40PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GTHXG1 Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GTHX